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ABSTRACT 
Introduction  
Recent evidence suggests an underlying movement disruption may be a core component of 
Autism Spectrum Disorder (ASD) and a new, accessible early biomarker.  Mobile smart 
technologies such as iPads contain inertial movement and touch-screen sensors capable of 
recording sub second movement patterns during gameplay.  A previous pilot study employed 
machine learning analysis of motor patterns recorded from children 3-5 years old.  It 
identified those with ASD from age- and gender-matched controls with 93% accuracy, 
presenting an attractive assessment method suitable for use in the home, clinic or classroom.   
Methods and Analysis 
This is a Phase III prospective, diagnostic classification study designed according to the 
Standards for Reporting Diagnostic Accuracy Studies (STARD) guidelines.  Three cohorts 
are investigated: children developing typically (TD); children with a clinical diagnosis of 
ASD; and children with a diagnosis of another neurodevelopmental disorder (OND) that is 
not ASD.  The study will be completed in Glasgow, U.K., and Gothenburg, Sweden.  The 
recruitment target is 760 children (280 TD, 280 ASD and 200 OND). Children play two 
games on the iPad then a third party data acquisition and analysis algorithm (Play.Care, 
Harimata sp. z o.o., Poland) will classify the data as positively or negatively associated with 
ASD.  The results are blind until data collection is complete, when the algorithmÕs 
classification will be compared against medical diagnosis.  Furthermore, parents of 
participants will complete three questionnaires: Strengths and Difficulties Questionnaire; 
ESSENCE Questionnaire; and the Adaptive Behavioural Assessment System.  The primary 
outcome measure is sensitivity and specificity of Play.Care to detect ASD.  Secondary 
outcomes include the ability of Play.Care to differentiate ASD from OND.  
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Ethics and Dissemination 
This study was approved by the Strathclyde University Ethics Committee and the West of 
Scotland Research Ethics Service Committee 3. Results will be disseminated at international 
scientific conferences and in peer reviewed publications.   
Trial registration 
ClinicalTrials.gov ID: NCT03438994 
Keywords 
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ARTICLE SUMMARY 
Strengths and limitations of this study  
¥! This is the first diagnostic study to evaluate the accuracy of a new iPad game based 
assessment for Autism Spectrum Disorder in pre-school aged children 
¥! Novel methods are used to collect accurate and reliable movement data as children 
play 
¥! Children with autism are compared to typically developing controls and children with 
other neurodevelopmental disorders which are not autism  
¥! This study offers the possibility for a new, non-subjective assessment method for 
autism 
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INTRODUCTION 
Autism spectrum disorder (ASD) is a childhood neurodevelopmental disorder with a 
prevalence estimated as high as 1 in 59 children in the United States [1]. In the UK, ca. 
700,000 individuals live with autism [2] and the aggregate annual cost of healthcare and 
support is £27.5 billion [3]. Early identification and consequent early therapeutic intervention 
may be valuable [4,5]: this may afford family and caregivers opportunity to adjust, and can 
trigger early healthcare intervention and childrenÕs services support.  Such provision can 
produce significant, lifelong health and economic benefit, e.g. [6,7]. 
Early diagnosis of children with autism remains complex and can be difficult to obtain.  
Diagnosis currently relies on specialist medical expertise with diagnostic instrumentation 
dependent on subjectively rated scores during child observations, parent interviews, and 
testing. These instruments are time consuming, clinically demanding and poorly validated 
against population controls.  Medical diagnosis can be withheld for many years due to wait-
list times or uncertainty in clinical diagnostic fit.  
Recent identification of motor disturbance in young children who develop ASD presents a 
new target for early assessment [8].  ASD is typically considered a social and emotional 
disorder. Therefore, current diagnostic instruments directly address social and emotional 
aspects of the syndrome.  However, motor control underpins social engagement, emotional 
expression, and cognitive development [9Ð12], and is accessible to non-invasive, ecologically 
valid assessment methods from the neonatal stage onward [13]. 
Children with ASD exhibit a clear deficit in movement, such as delays in the attainment of 
motor milestones [14], poor coordination [15,16], unusual gait patterns [17Ð20] and 
difficulties in gross and fine motor skills [21].  In a meta-analysis of all evidence, Fournier et 
al [22] concluded motor disruption to be a core feature of autism spectrum disorder.  This 
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motor perspective is beginning to gain significant clinical and research interest [23] and 
although movement differences in autism have not yet entered into the diagnostic criteria, the 
DSM-V now includes Ôawkward or clumsy gaitÕ as an associated symptom.  More work is 
required to characterize and determine how these motor differences manifest across the 
spectrum.  The motor signs identified in autism require differentiation from those that extend 
across the wider spectrum of early symptomatic syndromes eliciting neuropsychiatric clinical 
examination (ESSENCE; [24]). 
Recently, technological developments have miniaturised inertial movement unit sensors that 
now include tri-axial accelerometers, gyroscopes and magnetometers, together with touch-
sensitive screens integrated into mobile consumer smart devices such as phones, tablets, and 
wearable devices such as wristbands and watches.  These new devices provide 
unprecedented access to motor information with high levels of accuracy and reliability, 
previously restricted to high-end research or clinical laboratories.  
In previous work, Anzulewicz, Sobota and Delafield-Butt [25] tested a novel, serious smart 
tablet game for early identification of young children with autism.  Two attractive cartoon 
games were engineered with bespoke code to collect sensor data (inertial and touch screen 
sensors) as the children engaged for five minutes with each game.  Machine learning analysis 
identified those children diagnosed with autism with 93% accuracy, proving the principle 
that smart game identification of autism in children was a viable solution for ecological, 
accessible assessment.  Furthermore, this assessment methodology required no professional 
training to deploy, no verbal instructions were required to engage the child, and only limited 
supervision was necessary.  The result of the assessment is purely statistical; no subjective 
assessment is required.  Thus, we propose this serious game digital health tool could offer an 
attractive addition to the diagnosticianÕs tool box or serve as a paediatric public health 
screening tool.   
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The current best validated sub-component of the gold-standard in autism diagnosis, the 
Autism Diagnostic Observation Schedule (ADOS) Version 2, yields diagnostic performance 
of, at most, 91% sensitivity and 71% specificity, or 82% sensitivity and 88% specificity 
when the algorithm is adjusted to increase specificity [26].  The iPad serious game 
assessment, now called Play.Care, demonstrated a sensitivity and specificity of 83% and 
85%, respectively [25].  Serious game assessment by smart device appears to be an attractive 
resource that could improve sensitivity in autism diagnosis. 
The aim of this study is to validate the predictive value of the Play.Care assessment for 
autism diagnosis by conducting a multi-site, controlled diagnostic study.  Further aims 
include assessing the ability of Play.Care to differentiate ASD from other childhood 
developmental disorders.  The primary outcome measures will be sensitivity and specificity 
of Play.Care to detect ASD in the general population.  
Limitations inherent in the earlier pilot study are overcome in the diagnostic trial presented 
here.  The pilot study was based on a small sample of 82 children recruited from a small 
number of specialist day-care centres in Poland.  Such limited subject recruitment is prone to 
selection bias and site-specific effects and precludes assessment of predictive value in 
population-based settings.  Furthermore, the pilot study employed the same dataset to train 
and test the machine learning algorithm.  It did so with 10 repetitions of a 10-fold cross-
validation procedure that is not prone to over-fitting.  Nevertheless, it only trained and tested 
patterns on that particular dataset.  To alleviate both concerns, this study sets out to test the 
algorithm previously developed and published [25] on the new, blinded data obtained 
independently of the Play.Care software engineers in an international, multisite diagnostic 
evaluation with a general population cohort and Phase III clinical study structure and size.   
This trial is designed to test the Play.Care assessment to determine its generalized, real-world 
prediction rates across the range of possible ASD expression, as well as against TD and 
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OND variability.  Should the sensitivity and specificity of the assessment fall within 
clinically useful levels comparable to or exceeding current observer-rated tests (ADOS-2, 
Autism Diagnostic Interview - Revised; ADI-R), we expect this instrument to be an 
attractive and useful addition to the diagnostic tool box, accessible to a wide range of 
professionals in psychiatry, paediatrics and specialist childrenÕs services, including those in 
education.  This solution is attractive and timely, and benefits from the surge in machine 
learning analysis of smart tech device data.  In our case, this is a fun, useful and mobile 
serious game for autism assessment.   
METHODS AND ANALYSIS 
Study Design 
This study is a Phase III prospective, diagnostic classification study.  The protocol follows 
the Standards for Reporting Diagnostic accuracy studies (STARD) guidelines [27].  The 
study will be a multi-centre, international trial based in Glasgow, Scotland, UK and 
Gothenburg, Sweden.  The Glasgow cohort will comprise a clinical sample and the 
Gothenburg cohort will comprise a general population sample.  The study will have three 
groups of participants: children who have received a clinical diagnosis of ASD; children who 
have received a clinical diagnosis of an Other Neurodevelopmental Disorder (OND; see 
Table 2 for Inclusion/Exclusion criteria); and children developing typically (TD).  
Participants 
A total of 760 children aged thirty months to five years 11 months will be recruited. Table 1 
illustrates the participant numbers between sites and groups and Table 2 details 
inclusion/exclusion criteria for each group.  
Table 1. Participant numbers across groups and sites 
Site ASD OND TD Total 
Glasgow 100 140 180 420 
Gothenburg 180 60 100 340 
Total 280 200 280 760 
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Table 2. Participant inclusion and exclusion criteria 
Group Inclusion criteria Exclusion criteria 
All participants Aged 30 months to five years 11 
months 
 
Participants with a 
diagnosis of ASD 
Diagnosis of autism spectrum 
disorder on the basis of DSM-V 
criteria or equivalent ICD-10 
framework  
Uncorrected sensory (visual, 
hearing) impairments 
  Presence of any motor 
impairments or behavioural 
impairment that may obstruct 
testing 
 
Participants with a 
diagnosis of OND 
Other childhood developmental 
disorders including, but not limited 
to  Intellectual Disability, Non-
verbal Disability, Communication 
Disability, Attention Deficit 
Hyperactivity Disorder and 
Developmental Coordination 
Disorder, DownÕs Syndrome and 
Cerebral Palsy. 
Sub clinical or secondary 
expressions of ASD 
 
  Uncorrected hearing or vision 
impairments 
 
TD participants Within age range Diagnosis or suspicion of  
¥! Neuropathology 
¥! Psychopathology 
¥! Sensory or motor 
disorder including mild 
tremors  
 
Group sizes were decided upon by assuming Play.Care will achieve a moderate 85% 
sensitivity.  In this case, a study with 200 children with ASD will yield a confidence interval 
with a width of ± 4.9% i.e. the final sensitivity calculation will be accurate to within this 
range.  The target recruitment size for this group is 280 children to afford some reduction in 
sensitivity or a significant non-completion rate while preserving a narrow confidence interval.   
The wider population recruited in this study may reduce sensitivity, and inclusion of low 
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functioning children with ASD increases the likelihood of disengagement with, or disinterest 
in the Play.Care assessment.  Assuming a similar level of specificity, the same precision will 
be obtained with 200 TD children.  Furthermore, if the sensitivity (or specificity) is as high as 
90%, there will be 80% power to show that the sensitivity (or specificity) exceeds 83.0%, and 
90% power to show it exceeds 81.9%. On the other hand, if the sensitivity (or specificity) is 
only 70%, there will be 91% power to show that it is below 80%.  That is, if the Play.Care 
assessment is under performing, which is the major concern of healthcare services, this study 
has a high probability of detecting it.  
For the Glasgow cohort, recruitment of children with ASD or OND will be facilitated through 
the NHS Greater Glasgow and Clyde Specialist ChildrenÕs Services, namely the Southbank 
Child Development Centre, as well as specialist childrenÕs centres, nurseries, and schools.  
ASD and OND recruitment will occur via two streams. The first will recruit children who 
receive a positive diagnosis of ASD or OND following an assessment at the Southbank 
Centre.  The second will recruit children already diagnosed with ASD or OND from 
specialist nurseries, preschools and development centres.  Typically developing children will 
be recruited from local private nurseries in the Greater Glasgow area.  
The Gothenburg cohort is a general population sample as all children are screened for ASD 
within the Gothenburg area at 30 months.  Families of children screened positively for ASD 
are referred to the Gillberg Neuropsychiatry Centre (GNC) in Gothenburg for 
neuropsychiatric assessment and it is at this stage that families will be made aware of the 
study and asked if they would like to participate.  OND children in Gothenburg will be 
recruited through Speech and Language Therapists in collaboration with the GNC. 
Diagnostic Device 
The diagnostic tool under assessment in this study is the Play.Care iPad mini application, 
developed by Harimata sp. z o.o., Poland.  The assessment consists of two games played on 
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the iPad.  The first game is called ÔSharingÕ and requires the child to tap a piece of food to 
split it into four pieces, available for sharing with the four game characters waiting patiently 
(Figure 1a).  The second game is called ÔCreativityÕ and requires the child to trace the outline 
of a drawing and then colour it in (Figure 1b).  Each game consists of a two minute training 
phase where the researcher and/or parent can assist the child, and a five minute assessment 
phase where the child must play unassisted.  Following completion of the assessment, no 
further participation is required.  Anzulewicz et al. [25] details the data analytics employed, 
including identification of movement patterns by calculation of more than two hundred 
features that are assessed by an algorithm that statistically determines the diagnostic 
prediction.  
 
Figure 1.  Play.Care assessment games.   (a) ÔSharingÕ.  The child must tap the fruit to divide it into 
four and share it amongst game characters.  When all four characters have a slice of fruit, they express 
happiness for three seconds before the fruit is replaced with another food and the characters return to 
their neutral position.  (b) ÔCreativityÕ. The child is free to choose an object or animal which they 
must trace and then colour in freely by choosing a colour form the colour wheel.  If the child is 
satisfied, a new shape can be chosen at any time [25].   
The iPads used in this study are commercially available Apple products currently widely used 
for leisure, business and research.  The iPad specifications employed here are as follows: 
white bevel, silver back, non-cellular iPad mini 4, 128GB.  The iOS version will be the latest 
version available upon purchase of the iPads. These specifications will remain fixed for the 
duration of the study.  Furthermore, software updates will be switched off to prevent 
  
11 
 
automatic updates of iOS which may alter the sampling rate of the internal gyroscope and 
accelerometers.   
Procedure 
Potential participants in the ASD and OND assessment stream will first be approached by the 
clinician undertaking the assessment.  The family will be presented with the Patient 
Information Sheet (PIS) following a positive diagnosis and if the clinician judges them to be 
suitable participants.  The family will complete an interest slip indicating they are willing to 
be further contacted by the research team regarding the study.  This method was adopted to 
allow participation to be strictly Ôopt-inÕ and to prevent the research team contacting families 
who had not expressed an interest in participating.  After a minimum period of 24 hours, the 
research team will contact interested families to ask if they would like to participate and to 
arrange a data collection appointment. 
Potential participants in the ASD and OND already diagnosed stream will be first approached 
at their childÕs preschool where the research team will introduce the study during a parentÕs 
evening or similar event.  At this point, the PIS will be made available and families who are 
interested will complete an interest slip, as above, and after a minimum of 24 hours the 
research team will contact them.  
Potential participants who are developing typically will be recruited through local private 
nurseries.  Nursery staff will circulate the PIS amongst parents and those who wish their child 
to participate will return a completed consent form to the nursery.  Prior to completing the 
Play.Care assessment, informed consent will be given by the childÕs parents or caregivers.  
The researcher will then complete a Case Report Form (CRF) for participants in the ASD and 
OND groups which details study ID, Scottish Community Health Index (ÒCHIÓ) number, 
name, address, postcode, phone number and general practitioner (GP) details.  ParticipantsÕ 
CHI numbers will be recorded to allow follow up for up to 10 years following participation.  
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This will provide potential future insight into whether diagnoses remain consistent into 
adolescence and whether any other diagnoses are received.  Any further diagnoses can then 
be compared to the iPad data to determine any correlations between new diagnoses and 
movement characteristics in childhood.   
An electronic CRF (eCRF) will be completed detailing the childÕs emotional state on the day 
of data collection and a number of additional psychometric assessments including the 
Strengths and Difficulties Questionnaire (SDQ), the Early Symptomatic Syndromes Eliciting 
Neurodevelopmental Clinical Examinations Questionnaire (ESSENCE-Q) and the Adaptive 
Behaviour Assessment System (ABAS) at Glasgow and the Vinelands Adaptive Behaviour 
Scale (VABS) in Gothenburg.  In some cases, additional data will be recorded from 
instruments employed as part of the childÕs neuropsychiatric assessment: Wechsler Preschool 
and Primary Scale of Intelligence (WPPSI); Autism Diagnostic Interview Revised (ADI-R); 
and Autism Diagnostic Observation Schedule 2 (ADOS-2).  The diagnostic criteria that 
determine a childÕs diagnosis (ICD 10 or DSM V) will be recorded.  For participants in the 
ASD and OND groups, psychometric questionnaires will be completed at an appropriate time 
during or following the data collection appointment.   
Following completion of the CRF and eCRF, the child will complete the Play.Care 
assessment.  During the assessment, the iPad is protected within a spongy back-cover and 
bumper (iPad Mini2 Air Protect, Belkin, U.S.A.) and is placed flat on the table top, where it 
will remain for the duration of the assessment.  Parents/caregivers will have the option to 
consent to their child being videotaped during the assessment.  If consent is given, a video 
camera will be setup and recording will begin prior to the child starting the assessment.   
If a participant is unable to complete the assessment (e.g. they become distracted or 
distressed), eCRF and CRF data will still be recorded and the participant will remain a 
subject in the study.  This group will be classified as ÒPlay.Care incompletesÓ and will 
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provide insight into the clinical applicability of the assessment.  This group will be monitored 
at monthly intervals.  If the rate of Play.Care incompletes reaches a level where it will impact 
the statistical power of the study, administration protocols will be reviewed and adjusted to 
ensure best possible compliance.  This criterion will apply to the Glasgow cohort of 
participants only.  The Gothenburg cohort is a general population sample and therefore 
participation cannot be controlled dependent on failure rates.   If a participant does not have a 
confirmed clinical diagnosis by the end of the study, they will fall into the category of 
Òdiagnosis failuresÓ.  The acceptable level of diagnosis failures is 7.5%, or, up to 21 subjects 
in the ASD group and 15 in the OND group.  
Throughout the data collection phase, all members of the research team, the trial consortium 
and Harimata will be blinded to the Play.Care diagnostic prediction until all data have been 
collected.  Following data collection, clinical diagnoses will be compared with Play.Care 
diagnostic predictions.  The primary outcome measure is the ability of Play.Care to identify 
ASD cases within the general population (Gothenburg) and clinic (Glasgow) by assessing 
classification efficacy against TD children.  The secondary outcome measures are the ability 
of Play.Care to differentiate these ASD children from OND children and to correlate 
movement data to adaptive behaviour scores.   
Patient and Public Involvement  
The public have not been involved in the development of the study protocol. Patients will be 
involved as study participants and a lay summary of the results will be made available to 
families who participated.  
ETHICS AND DISSEMINATION 
This study was granted approval by the Strathclyde University Ethics Committee and the 
West of Scotland Research Ethics Service Committee 3 (reference number: 17-WS-0223 
231435). Following completion of data collection, results will be disseminated internally at 
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Strathclyde University via the Laboratory for Innovation in Autism website, via a final report 
to Harimata sp. z o.o., at national and international scientific conferences and in peer 
reviewed scientific journals. A lay summary of study results will also be provided for 
participating families.    
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